• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴雷特食管:肿瘤进展晚期的细胞周期异常

Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.

作者信息

Reid B J, Sanchez C A, Blount P L, Levine D S

机构信息

Department of Medicine, University of Washington, Seattle.

出版信息

Gastroenterology. 1993 Jul;105(1):119-29. doi: 10.1016/0016-5085(93)90017-7.

DOI:10.1016/0016-5085(93)90017-7
PMID:8514029
Abstract

BACKGROUND

Abnormal proliferation in Barrett's esophagus may predispose to the development of esophageal adenocarcinoma, but previous studies have not determined the specific cell cycle abnormalities that were associated with neoplastic progression.

METHODS

Ki67/DNA content multiparameter flow cytometry and DNA content flow cytometry were used to investigate G0, G1, and S phase fractions in advancing stages of neoplastic progression in Barrett's esophagus.

RESULTS

In control biopsy specimens from gastric mucosa, G1, S phase, and total Ki67-positive proliferative fractions were low, suggesting that cells were predominantly in G0. Ki67-positive G1 fractions were increased in Barrett's metaplasia. More advanced stages of neoplastic progression were characterized by a subset of biopsy specimens that had aneuploid cell populations, increased S phase fractions, or both.

CONCLUSIONS

The development of increased G1 fractions is an early event in Barrett's metaplasia. Increased S phase fractions occur in a subset of specimens typically at more advanced stages of neoplastic progression and often in association with the development of aneuploidy. Neoplastic progression in Barrett's esophagus is associated with at least three types of cell cycle abnormalities: (1) mobilization from G0 into G1; (2) loss of control of the G1/S phase transition; and (3) accumulation in G2.

摘要

背景

巴雷特食管中的异常增殖可能易导致食管腺癌的发生,但以往研究尚未确定与肿瘤进展相关的具体细胞周期异常情况。

方法

采用Ki67/DNA含量多参数流式细胞术和DNA含量流式细胞术,研究巴雷特食管肿瘤进展各阶段的G0、G1和S期比例。

结果

在胃黏膜对照活检标本中,G1期、S期以及总的Ki67阳性增殖比例较低,提示细胞主要处于G0期。巴雷特化生中Ki67阳性G1期比例增加。肿瘤进展更高级阶段的特征是部分活检标本具有非整倍体细胞群、S期比例增加或两者皆有。

结论

G1期比例增加是巴雷特化生的早期事件。S期比例增加出现在部分标本中,通常是在肿瘤进展的更高级阶段,且常与非整倍体的发生相关。巴雷特食管的肿瘤进展与至少三种细胞周期异常有关:(1)从G0期进入G1期;(2)G1/S期转换失控;(3)在G2期积累。

相似文献

1
Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression.巴雷特食管:肿瘤进展晚期的细胞周期异常
Gastroenterology. 1993 Jul;105(1):119-29. doi: 10.1016/0016-5085(93)90017-7.
2
Cell proliferation, cell cycle abnormalities, and cancer outcome in patients with Barrett's esophagus: a long-term prospective study.巴雷特食管患者的细胞增殖、细胞周期异常与癌症结局:一项长期前瞻性研究。
Clin Cancer Res. 2008 Nov 1;14(21):6988-95. doi: 10.1158/1078-0432.CCR-07-5063.
3
Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort.巴雷特食管向恶性肿瘤的流式细胞术和组织学进展:队列的前瞻性内镜监测
Gastroenterology. 1992 Apr;102(4 Pt 1):1212-9.
4
Correlation of ultrastructural aberrations with dysplasia and flow cytometric abnormalities in Barrett's epithelium.巴雷特食管上皮超微结构异常与发育异常及流式细胞术异常的相关性
Gastroenterology. 1989 Feb;96(2 Pt 1):355-67. doi: 10.1016/s0016-5085(89)91559-x.
5
Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus.
Cancer Res. 1995 May 1;55(9):1971-6.
6
Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.Ki-67增殖区的扩大与巴雷特食管的发育异常程度相关。
Cancer. 1995 Jan 15;75(2):423-9. doi: 10.1002/1097-0142(19950115)75:2<423::aid-cncr2820750202>3.0.co;2-5.
7
Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry.通过双参数流式细胞术评估巴雷特食管中p53蛋白的表达。
Gastroenterology. 1992 Apr;102(4 Pt 1):1220-8.
8
Progression to cancer in Barrett's esophagus is associated with genomic instability.巴雷特食管进展为癌症与基因组不稳定有关。
Lab Invest. 1989 Jan;60(1):65-71.
9
Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.细胞凋亡的抑制不会促进巴雷特食管的肿瘤生长。
Mod Pathol. 1999 Mar;12(3):239-50.
10
Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.非整倍体以及Ki67和p53的过表达作为巴雷特食管肿瘤进展的标志物:一项病例对照研究。
Am J Gastroenterol. 2009 Nov;104(11):2673-80. doi: 10.1038/ajg.2009.437. Epub 2009 Jul 28.

引用本文的文献

1
Barrett's Esophagus: An Updated Review.巴雷特食管:最新综述
Diagnostics (Basel). 2023 Jan 16;13(2):321. doi: 10.3390/diagnostics13020321.
2
Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma.在早期食管腺癌患者接受治疗后,其血清中双皮质素样激酶1水平升高的情况会恢复至基线水平。
Biomark Res. 2019 Mar 8;7:5. doi: 10.1186/s40364-019-0157-z. eCollection 2019.
3
Economic value of narrow-band imaging versus white light endoscopy for the diagnosis and surveillance of Barrett's esophagus: Cost-consequence model.
窄带成像与白光内镜诊断和监测 Barrett 食管的经济学价值:成本-效果模型。
PLoS One. 2019 Mar 13;14(3):e0212916. doi: 10.1371/journal.pone.0212916. eCollection 2019.
4
Gastroesophageal reflux and Barrett's esophagus: a pathway to esophageal adenocarcinoma.胃食管反流与巴雷特食管:通向食管腺癌的途径。
Updates Surg. 2018 Sep;70(3):339-342. doi: 10.1007/s13304-018-0564-y. Epub 2018 Jul 23.
5
Quantitation of spatial and temporal variability of biomarkers for Barrett's Esophagus.巴雷特食管生物标志物的空间和时间变异性定量分析。
Dis Esophagus. 2017 Sep 1;30(9):1-8. doi: 10.1093/dote/dox023.
6
From Heartburn to Barrett's Esophagus, and Beyond.从胃灼热到巴雷特食管,以及其他情况。
World J Surg. 2017 Jul;41(7):1698-1704. doi: 10.1007/s00268-017-3957-z.
7
Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus.细胞凋亡敏感性蛋白CAS/CSE1L的表达与巴雷特食管的肿瘤进展相关。
Appl Immunohistochem Mol Morphol. 2018 Sep;26(8):552-556. doi: 10.1097/PAI.0000000000000464.
8
A Systematic Review of Esophageal MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus.用于巴雷特食管诊断和监测的食管微小RNA标志物的系统评价
Dig Dis Sci. 2016 Apr;61(4):1039-50. doi: 10.1007/s10620-015-3959-3. Epub 2015 Nov 14.
9
ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus.美国胃肠病学会临床指南:巴雷特食管的诊断与管理
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51. doi: 10.1038/ajg.2015.322. Epub 2015 Nov 3.
10
Biomarkers of Barrett's esophagus.巴雷特食管的生物标志物。
World J Gastrointest Pathophysiol. 2014 Nov 15;5(4):450-6. doi: 10.4291/wjgp.v5.i4.450.